Target intelligence / Profile preview

Inflammatory and immune pathways in the kidney microenvironment

Molecular classification
Other, Cytokine, Chemokine, Enzyme, Receptor, Transcription factor
01

Overview

The inflammatory and immune pathways in the kidney microenvironment represent a complex network of cellular and molecular interactions that govern the organ's response to injury and disease. This microenvironment involves resident cells, such as podocytes and tubular epithelial cells, interacting with infiltrating immune cells like macrophages, T cells, and neutrophils through various signaling cascades including the complement system, TLR signaling, and the NLRP3 inflammasome (Anders et al., 2018, Nature Reviews Nephrology). Dysregulation of these pathways is a central driver in the progression of chronic kidney disease (CKD) and acute kidney injury (AKI), where persistent inflammation leads to maladaptive repair and renal fibrosis (Tang & Flynn, 2015, Journal of the American Society of Nephrology). Therapeutic strategies often focus on specific nodes within these pathways, such as cytokine receptors or intracellular kinases, to dampen the inflammatory response and preserve renal function (Ruiz-Ortega et al., 2020, Nature Reviews Nephrology). However, because these pathways are often essential for host defense, targeting them requires a balance between therapeutic efficacy and the risk of systemic immunosuppression.

Other names
Renal inflammatory microenvironmentIntrarenal immune signalingKidney immune landscapeRenal immune milieu
02

Mechanism of action

Modulation of specific components within the renal microenvironment, such as complement inhibition, JAK/STAT signaling blockade, or reduction of pro-inflammatory cytokine production to prevent tissue damage and fibrosis.

03

Biological functions

Immune responseInflammationSignal transductionApoptosisCell proliferationTissue repairFibrosis
04

Disease associations

Chronic kidney diseaseAcute kidney injuryLupus nephritisDiabetic nephropathyGlomerulonephritisIgA nephropathy
05

Safety considerations

Systemic immunosuppressionIncreased susceptibility to opportunistic infectionsPotential for impaired wound healingOff-target effects on systemic homeostasisRisk of reactivation of latent infections (e.g., tuberculosis)
06

Interacting drugs

Eculizumab

6 more in the full profile.

07

Biomarkers

Kidney injury molecule-1 (KIM-1)Neutrophil gelatinase-associated lipocalin (NGAL)Monocyte chemoattractant protein-1 (MCP-1)Urinary albumin-to-creatinine ratio (UACR)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Inflammatory and immune pathways in the kidney microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory and immune pathways in the kidney microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call